Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score AnalysisFélix Ackermann, Anne‐Laure Brun, Charles Cerf et al.|Journal of Clinical Immunology|2020Cited by 53
Improved performances of the second generation of the ID NOW influenza A&B 2® and comparison with the GeneXpert®Éric Farfour, Marc Vasse, Antoine Roux et al.|European Journal of Clinical Microbiology & Infectious Diseases|2020Cited by 13
Tocilizumab to Prevent Ventilatory Support for Severe Worsening COVID-19 Pneumonia: A Propensity Score AnalysisMathilde Roumier, Félix Ackermann, Romain Paule et al.|SSRN Electronic Journal|2020Cited by 1